Back    Zoom +    Zoom -
<Research>CLSA: Decline in WUXI BIO/ WUXI XDC on Thu Not Driven by Fundamentals
Recommend
5
Positive
9
Negative
1
WUXI BIO (02269.HK) and WUXI XDC (02268.HK) stumbled by approx. 7% and 8% on Thursday (26th), while Hong Kong-listed CRO/CDMO companies lost by about 2-to 9% overall, CLSA released a research report saying. The broker believed that this decline is not driven by fundamentals but is more likely largely positioning and capital flow-led.

The current pullback is technical/short-term volatility rather than a result of deteriorating demand or execution capability, the report added. In a market window lacking catalysts, industry leaders may still overshoot on the downside, creating more attractive entry opportunities for investors with a 3-12 month investment horizon.

Related NewsM Stanley Cuts TP for WUXI XDC (02268.HK) to HKD86, Rating Overweight

AAStocks Financial News
Website: www.aastocks.com